Physician profile
Andrew Hearn
NPI 1922694025
$1,337.05
in general payments reported to CMS, 2019-2025
17 companies · $1,199 in 2025
The $1,199 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $138 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,121 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.89 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $388.48 | 2025 | Enhertu, Datroway, Injectafer |
| Novartis Pharmaceuticals Corporation | $214.41 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $147.59 | 2025 | Libtayo |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2022 | |
| Merck Sharp & Dohme LLC | $69.04 | 2025 | Keytruda, Keytruda Qlex, Lynparza |
| Pfizer INC. | $54.35 | 2022-2025 | |
| Pharmaessentia USA Corporation | $53.97 | 2025 | Besremi |
| Aveo Pharmaceuticals, INC. | $49.29 | 2025 | |
| Puma Biotechnology, INC. | $38.43 | 2025 | |
| Emd Serono, INC. | $31.38 | 2025 | |
| Incyte Corporation | $28.54 | 2025 | Jakafi |
| Immunocore Limited | $26.42 | 2025 | Kimmtrak |
| Genentech USA, INC. | $25.85 | 2025 | Tecentriq |
| Sobi, INC | $24.46 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.06 | 2025 | Iclusig |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $18.32 | 2025 | Ultomiris |
| Sandoz INC. | $17.47 | 2025 | Jubbonti, Wyost |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hearn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.